guhjy's hcc [at least 200 articles] Export

Recent papers added to guhjy's library classified by the tag hcc. You can also see everyone's hcc.

	Molecular targeting for treatment of advanced hepatocellular carcinoma. [My Copy] The Korean journal of hepatology, Vol. 15, No. 3. (September 2009), pp. 299-308. by Il Han H. Song posted to targeted-therapy hcc by guhjy on 2009-11-26 01:55:45 as
	Targeted therapy for hepatocellular carcinoma. [My Copy] Nature reviews. Gastroenterology & hepatology, Vol. 6, No. 7. (July 2009), pp. 423-432. by Hans Christian C. Spangenberg, Robert Thimme, Hubert E. Blum posted to targeted-therapy hcc by guhjy on 2009-11-26 01:55:41 as
	Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma. [My Copy] Cancer chemotherapy and pharmacology, Vol. 64, No. 3. (August 2009), pp. 497-507. by Won Kim, Jung-Hwan H. Yoon, Jung-Ryul R. Kim, et al.In-Jin J. Jang, Yung-Jue J. Bang, Yoon-Jun J. Kim, Hyo-Suk S. Lee posted to statin pkc inhibitor hcc by guhjy on 2009-11-21 14:34:13 as
	Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. [My Copy] Hepatology (Baltimore, Md.), Vol. 47, No. 1. (January 2008), pp. 97-104. by Alejandro Forner, Ramón Vilana, Carmen Ayuso, et al.Lluís Bianchi, Manel Solé, Juan Ramón R. Ayuso, Loreto Boix, Margarita Sala, María Varela, Josep M. Llovet, Concepció Brú, Jordi Bruix posted to hcc by guhjy on 2009-11-18 02:19:20 as
	Cross-talk between IFN-alpha and TGF-beta1 signaling pathways in preneoplastic rat liver. [My Copy] Growth factors (Chur, Switzerland), Vol. 27, No. 1. (February 2009), pp. 1-11. by María De Luján d. e. . L. Alvarez, Ariel D. Quiroga, Juan P. Parody, et al.María Teresa T. Ronco, Daniel E. Francés, Cristina E. Carnovale, María Cristina C. Carrillo posted to tgfb ifn hcc by guhjy on 2009-11-17 02:33:34 as
	Vascular changes in hepatocellular carcinoma. [My Copy] Anatomical record (Hoboken, N.J. : 2007), Vol. 291, No. 6. (June 2008), pp. 721-734. by Zhen Fan F. Yang, Ronnie T. Poon posted to hcc angiogenesis by guhjy on 2009-11-17 02:31:15 as
	JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma. [My Copy] Molecular cancer, Vol. 8 (17 August 2009), 64. by Qingshan Chang, Jianguo Chen, Kevin J. Beezhold, Vince Castranova, Xianglin Shi, Fei Chen posted to jnk hcc by guhjy on 2009-11-17 02:31:09 as
	Beyond apoptosis of JNK1 in liver cancer. [My Copy] Cell cycle (Georgetown, Tex.), Vol. 8, No. 8. (15 April 2009), pp. 1145-1147. by Fei Chen, Vince Castranova posted to jnk hcc apoptosis by guhjy on 2009-11-17 02:31:02 as
	Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion. [My Copy] Carcinogenesis, Vol. 30, No. 9. (September 2009), pp. 1487-1496. by Roland Kaufmann, Claudia Oettel, Antje Horn, et al.Karl-Jürgen J. Halbhuber, Annett Eitner, Reimar Krieg, Kathrin Katenkamp, Peter Henklein, Martin Westermann, Frank D. Böhmer, Rithwik Ramachandran, Mahmoud Saifeddine, Morley D. Hollenberg, Utz Settmacher posted to met hcc by guhjy on 2009-11-17 02:29:58 as
	Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures. [My Copy] Cancer, Vol. 115, No. 16. (15 August 2009), pp. 3738-3748. by Chiara Braconi, Fanyin Meng, Erica Swenson, Lyudmyla Khrapenko, Nianyuan Huang, Tushar Patel posted to ma hcc by guhjy on 2009-11-17 02:29:29 as
	Pathogenesis of hepatocellular carcinoma and molecular therapies. [My Copy] Current opinion in gastroenterology, Vol. 25, No. 3. (May 2009), pp. 186-194. by Beatriz Mínguez, Victoria Tovar, Derek Chiang, Augusto Villanueva, Josep M. Llovet posted to targeted-therapy hcc by guhjy on 2009-11-17 02:29:18 as
	Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer. [My Copy] Journal of hepatology, Vol. 50, No. 2. (February 2009), pp. 323-333. by Qingshan Chang, Yadong Zhang, Kevin J. Beezhold, et al.Deepak Bhatia, Hongwen Zhao, Jianguo Chen, Vince Castranova, Xianglin Shi, Fei Chen posted to jnk hcc by guhjy on 2009-11-17 02:28:52 as
	Rho GTPases in hepatocellular carcinoma. [My Copy] Biochimica et biophysica acta, Vol. 1795, No. 2. (April 2009), pp. 137-151. by Florence Grise, Aurélien Bidaud, Violaine Moreau posted to rho hcc by guhjy on 2009-11-17 02:28:49 as
	Role of PKCbeta in hepatocellular carcinoma cells migration and invasion in vitro: a potential therapeutic target. [My Copy] Clinical & experimental metastasis, Vol. 26, No. 3. (2009), pp. 189-195. by Kun Guo, Yan Li, Xiaonan Kang, et al.Lu Sun, Jiefeng Cui, Dongmei Gao, Yinkun Liu posted to pkc hcc by guhjy on 2009-11-17 02:27:56 as
	Sorafenib: a review of its use in advanced hepatocellular carcinoma. [My Copy] Drugs, Vol. 69, No. 2. (2009), pp. 223-240. by Gillian M. Keating, Armando Santoro posted to sorafenib hcc by guhjy on 2009-11-17 02:26:00 as
	Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials. [My Copy] Journal of cancer research and clinical oncology, Vol. 135, No. 12. (December 2009), pp. 1685-1692. by Tian-Kang K. Guo, Xiang-Yong Y. Hao, Bin Ma, et al.Ke-Hu H. Yang, Yi-Ping P. Li, Hong-Ling L. Li, Yuan-Hui H. Gu, Hui Cai, Ya-Li L. Liu, Yuan Li, Wei-Peng P. Zhan posted to octreotide hcc by guhjy on 2009-11-17 02:25:41 as
	Medical treatments: in association or alone, their roles and their future perspectives : The Western experience. [My Copy] Journal of hepato-biliary-pancreatic surgery (5 November 2009) by Maria Reig, Jordi Bruix posted to sorafenib hcc by guhjy on 2009-11-17 02:25:35 as
	Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. [My Copy] Oncogene, Vol. 28, No. 45. (12 November 2009), pp. 4022-4033. by F. van Zijl, M. Mair, A. Csiszar, et al.D. Schneller, G. Zulehner, H. Huber, R. Eferl, H. Beug, H. Dolznig, W. Mikulits posted to hcc emt by guhjy on 2009-11-17 02:12:19 as
	Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma. [My Copy] Digestive diseases (Basel, Switzerland), Vol. 27, No. 2. (2009), pp. 93-101. by Steven Dooley, Honglei Weng, Peter R. Mertens posted to tgfb hcc by guhjy on 2009-11-17 02:08:33 as
	Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma. [My Copy] Journal of cancer research and clinical oncology, Vol. 135, No. 5. (May 2009), pp. 715-722. by Zheng Wang, Jian Zhou, Jia Fan, et al.Chang-Jun J. Tan, Shuang-Jian J. Qiu, Yao Yu, Xiao-Wu W. Huang, Zhao-You Y. Tang posted to rapamycin hcc by guhjy on 2009-11-14 05:02:18 as
	Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma. [My Copy] Oncology reports, Vol. 20, No. 4. (October 2008), pp. 713-719. by Wei Li, Dongfeng Tan, Zhaoping Zhang, John J. Liang, Robert E. Brown posted to s6k mtor hcc akt by guhjy on 2009-11-13 04:19:09 as
	Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection. [My Copy] Journal of gastroenterology, Vol. 44 Suppl 19, No. 0. (1 January 2009), pp. 82-88. by Kazuhiko Koike posted to nash hcv hcc by guhjy on 2009-11-04 02:18:58 as
	Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. [My Copy] Hepatology (Baltimore, Md.), Vol. 50, No. 5. (10 November 2009), pp. 1464-1474. by Muh-Hwa H. Yang, Chih-Li L. Chen, Gar-Yang Y. Chau, et al.Shih-Hwa H. Chiou, Chien-Wei W. Su, Teh-Ying Y. Chou, Wei-Li L. Peng, Jaw-Ching C. Wu posted to twist snail hcc by guhjy on 2009-10-29 06:07:52 as
	Des-gamma-carboxy Prothrombin and Alpha fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma. [My Copy] Gastroenterology (20 October 2009) by Anna S. Lok, Richard K. Sterling, James E. Everhart, et al.Elizabeth C. Wright, John C. Hoefs, Adrian M. Di Bisceglie, Timothy R. Morgan, Hae-Young Y. Kim, William M. Lee, Herbert L. Bonkovsky, Jules L. Dienstag, HALT-C Trial Group posted to hcc halt-c afp by guhjy on 2009-10-29 02:31:55 as
	Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma. [My Copy] Liver international : official journal of the International Association for the Study of the Liver (22 October 2009) by Teh-Ia I. Huo, Chia-Yang Y. Hsu, Yi-Hsiang H. Huang, et al.Cheng-Yuan Y. Hsia, Han-Chieh C. Lin, Pui-Ching C. Lee, Che-Chuan C. Loong, Jen-Huey H. Chiang, Yi-You Y. Chiou, Shou-Dong D. Lee posted to hrs hcc dm aki by guhjy on 2009-10-29 02:27:26 as
	Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. [My Copy] World journal of surgery, Vol. 33, No. 11. (November 2009), pp. 2412-2419. by Kuang-Yu Y. Hsu, Gar-Yang Y. Chau, Wing-Yiu Y. Lui, Shyh-Haw H. Tsay, Kuang-Liang L. King, Chew-Wun W. Wu posted to mortality meld hcc by guhjy on 2009-10-29 02:27:17 as
	Hepatocellular carcinoma--epidemiological trends and risk factors. [My Copy] Digestive diseases (Basel, Switzerland), Vol. 27, No. 2. (2009), pp. 80-92. by Kerstin Schütte, Jan Bornschein, Peter Malfertheiner posted to hcc by guhjy on 2009-10-29 01:58:11 as
	Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study. [My Copy] Cancer causes & control : CCC (19 September 2009) by Akane Ui, Shinichi Kuriyama, Masako Kakizaki, et al.Toshimasa Sone, Naoki Nakaya, Kaori Ohmori-Matsuda, Atsushi Hozawa, Yoshikazu Nishino, Ichiro Tsuji posted to tea japan hcc by guhjy on 2009-10-29 01:57:55 as along with 1 person teatable
	Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. [My Copy] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 18, No. 6. (June 2009), pp. 1746-1753. by Manami Inoue, Norie Kurahashi, Motoki Iwasaki, et al.Taichi Shimazu, Yasuhito Tanaka, Masashi Mizokami, Shoichiro Tsugane, Japan Public Health Center-Based Prospective Study Group posted to tea japan hcc coffee by guhjy on 2009-10-29 01:57:26 as along with 1 person menlha
	Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. [My Copy] Hepatology (Baltimore, Md.), Vol. 50, No. 1. (July 2009), pp. 175-184. by George N. Ioannou, Olivia B. Morrow, Marah L. Connole, Sum P. Lee posted to nutrient nhanes lc hcc diet by guhjy on 2009-10-29 01:56:48 as
	Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. [My Copy] Gastroenterology, Vol. 136, No. 7. (June 2009), pp. 2304-2315.e4. by Shigeki Sekine, Reiko Ogawa, Rie Ito, et al.Nobuyoshi Hiraoka, Michael T. McManus, Yae Kanai, Matthias Hebrok posted to ko hcc dicer by guhjy on 2009-09-01 09:26:58 as
	Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. [My Copy] Hepatology (Baltimore, Md.), Vol. 50, No. 2. (August 2009), pp. 490-499. by Xiaoying Zhang, Shanrong Liu, Tingsong Hu, Shupeng Liu, Ying He, Shuhan Sun posted to nfkb mirna hcc by guhjy on 2009-08-27 07:31:56 as
	Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. [My Copy] Nature, Vol. 457, No. 7226. (8 January 2009), pp. 200-204. by Sandra Rebouissou, Mohamed Amessou, Gabrielle Couchy, et al.Karine Poussin, Sandrine Imbeaud, Camilla Pilati, Tina Izard, Charles Balabaud, Paulette Bioulac-Sage, Jessica Zucman-Rossi posted to inflammation hcc gp130 by guhjy on 2009-08-27 03:16:46 as
	JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand. [My Copy] Gut, Vol. 58, No. 5. (May 2009), pp. 688-698. by S. R. Mucha, A. Rizzani, A. L. Gerbes, et al.P. Camaj, W. E. Thasler, C. J. Bruns, S. T. Eichhorst, E. Gallmeier, F. T. Kolligs, B. Göke, E. N. De Toni posted to tnf jnk inhibitor hcc apoptosis by guhjy on 2009-08-23 15:54:45 as
	Forkhead transcription factor FoxO1 inhibits insulin- and transforming growth factor-beta-stimulated plasminogen activator inhibitor-1 expression. [My Copy] Biochemical and biophysical research communications, Vol. 386, No. 4. (4 September 2009), pp. 757-761. by Yun-A A. Jung, Kyeong-Min M. Lee, Mi-Kyung K. Kim, et al.Gwon-Soo S. Jung, Ye-Jin J. Seo, Hye-Soon S. Kim, Ho-Chan C. Cho, Ki-Up U. Lee, Keun-Gyu G. Park, In-Kyu K. Lee posted to tgfb pai1 insulin hcc foxo by guhjy on 2009-08-23 15:26:43 as along with 1 person and 1 group HEIRS HEIRS - Environmental Illness Research
	A model of interaction: Aflatoxins and hepatitis viruses in liver cancer aetiology and prevention [My Copy] Cancer Letters (02 April 2009) by Christopher P. Wild, Ruggero Montesano posted to hcv hcc aflatoxin by guhjy on 2009-08-18 02:42:45 as
	Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis [My Copy] Gastroenterology, Vol. 132, No. 7. (June 2007), pp. 2557-2576. by H. Elserag, K. Rudolph posted to hcc by guhjy on 2009-08-18 02:41:45 as along with 1 person amabeise
	Novel treatments for hepatocellular cancer. [My Copy] Cancer letters, Vol. 286, No. 1. (1 December 2009), pp. 114-120. by S. H. Kerr, D. J. Kerr posted to targeted-therapy sorafenib hcc by guhjy on 2009-08-18 02:37:36 as
	Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study. [My Copy] The lancet oncology, Vol. 10, No. 8. (August 2009), pp. 794-800. by Sandrine Faivre, Eric Raymond, Eveline Boucher, et al.Jean Douillard, Ho Y. Lim, Jun S. Kim, Magaly Zappa, Silvana Lanzalone, Xun Lin, Samuel Deprimo, Charles Harmon, Ana Ruiz-Garcia, Maria J. Lechuga, Ann Lii L. Cheng posted to targeted-therapy rct hcc by guhjy on 2009-08-18 02:37:28 as
	Deciphering Hepatocellular Carcinoma: From Bench to Bedside and Back [My Copy] Gastroenterology (28 July 2009) by Wolfram Goessling posted to hcc by guhjy on 2009-08-18 02:37:07 as
	Sorafenib for liver cancer: the horizon broadens [My Copy] The Lancet Oncology, Vol. 10, No. 1. (January 2009), pp. 4-5. by P. Johnson, L. Billingham posted to sorafenib hcc by guhjy on 2009-08-17 06:11:25 as
	Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo☆ [My Copy] Journal of Hepatology (12 June 2009) by Pippa Newell, Sara Toffanin, Augusto Villanueva, et al.Derek Y. Chiang, Beatriz Minguez, Laia Cabellos, Radoslav Savic, Yujin Hoshida, Kiat H. Lim, Pedro Melgar-Lesmes posted to sorafenib ras mtor hcc by guhjy on 2009-08-17 06:07:22 as
	NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy. [My Copy] Cancer letters, Vol. 278, No. 2. (18 June 2009), pp. 145-155. by Jian-Min M. Wu, Hongmiao Sheng, Romil Saxena, et al.Nicholas James J. Skill, Poornima Bhat-Nakshatri, Menggang Yu, Harikrishna Nakshatri, Mary A. Maluccio posted to targeted-therapy sorafenib nfkb hcc by guhjy on 2009-08-17 06:07:12 as
	Sorafenib in Advanced Hepatocellular Carcinoma: A Further Step Toward Personalized Therapy of Liver Cancer [My Copy] Gastroenterology, Vol. 136, No. 5. (May 2009), pp. 1832-1835. by Massimo Colombo posted to sorafenib hcc by guhjy on 2009-08-17 06:06:58 as
	JNK1, a potential therapeutic target for hepatocellular carcinoma. [My Copy] Biochimica et biophysica acta, Vol. 1796, No. 2. (08 December 2009), pp. 242-251. by Fei Chen, Kevin Beezhold, Vince Castranova posted to jnk hcc by guhjy on 2009-08-17 06:05:33 as
	Sorafenib for hepatocellular carcinoma: global validation [My Copy] Gastroenterology (24 July 2009) by Maria Reig, Jordi Bruix posted to vegf sorafenib hcc by guhjy on 2009-08-17 06:05:27 as
	Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma. [My Copy] Minerva gastroenterologica e dietologica, Vol. 55, No. 2. (June 2009), pp. 123-138. by K. Hussain, H. B. El-Serag posted to hcc by guhjy on 2009-08-10 03:39:01 as
	Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. [My Copy] Journal of viral hepatitis, Vol. 16, No. 7. (July 2009), pp. 453-463. by V. T. Nguyen, M. G. Law, G. J. Dore posted to hbv hcc by guhjy on 2009-08-10 03:38:40 as
	Prevention of hepatocellular carcinoma complicating chronic hepatitis C. [My Copy] Journal of gastroenterology and hepatology, Vol. 24, No. 4. (April 2009), pp. 531-536. by Yoshiyuki Ueno, Jose D. Sollano, Geoffrey C. Farrell posted to hcc hcv by guhjy on 2009-08-10 03:38:12 as
	Hepatocellular carcinoma in the Asia pacific region. [My Copy] Journal of gastroenterology and hepatology, Vol. 24, No. 3. (March 2009), pp. 346-353. by Man-Fung F. Yuen, Jin-Lin L. Hou, Anuchit Chutaputti, Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma posted to asia hcc by guhjy on 2009-08-10 03:37:43 as

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/tag/hcc

Result page: 1 2 3 4 5 Next

ckd	1736
rct	1195
dn	1078
dm	997
cancer	988
ma	969
cv	906
hd	856
tgfb	791
snp	760
bp	637
ros	570
meta-analysis	515
uae	498
stats	476
kidney	473
software	460
mouse	454
genetics	444
mirna	442
pt	417
proteomics	409
mortality	408
inflammation	363
fbl	359
rat	355
proteinuria	355
pcr	348
tw	345
acei	330
gdl	328
db	326
test	325
inhibitor	315
urine	315
arb	312
method	311
ms	309
apoptosis	302
hcv	300
mc	299
age	298
r	291
aging	287
biomarker	285
irs	280
ppi	275
bias	274
akt	274
bayes	273
gwa	267
mtor	266
aki	265
aii	261
hg	258
nutrition	255
emt	242
rnai	242
ub	237
p53	231
fibrosis	231
egfr	230
cox	226
smad	221
pbmc	220
obesity	219
pi3k	214
metab	212
drug	211
hcc	210
gn	208
hypoxia	204
1	204
herb	197
erk	190
albumin	189
lc	185
collagen	182
longitudinal	179
hif	179
lmm	178
nfkb	176
stz	176
gfr	174
ua	170
pubmed	169
epigenetics	169
japan	165
p38	162
gender	162
cea	160
power	159
lead	159
rage	159
cadmium	158
dna-damage	157
bioinf	155
ref	154
genomics	148
stata	147
vitamin-d	146
ctgf	144
network	142
liver	138
screening	137
rt	135
diet	133
seq	131
company	129
protein	128
phosphorylation	127
go	125
systems-biology	124
pathway	122
cell-cycle	121
mt	120
no	120
book	119
pkc	117
esrd	117
lipid	117
creatinine	115
statin	114
kinase	113
senescence	106
podocyte	105
proliferation	105
s6k	104
mapk	103
fish	103
regression	103
pd	102
gfr-formula	102
case-control	102
imputation	101
cad	100
imaging	99
plasmid	97
rx	97
multiplicity	96
insulin	96
cloning	96
observational	95
pediatric	95
p21	95
methylation	95
recurrent	94
sirt	93
blood	91
betel	91
nhanes	90
nox	90
tnf	90
website	89
pparg	89
chf	88
phenotype	88
toxicology	88
anemia	87
cytokine	87
diagnosis	87
src	86
immunity	86
uti	85
stat	85
lr	84
at1	84
china	83
epo	82
p	81
oat	81
nonp	81
hapmap	80
cachexia	80
environment	79
ca	79
ebm	79
hypertrophy	78
gout	78
primer	78
qms	76
review	75
autophagy	73
gene-therapy	73
missing	73
promoter	73
eqtl	72
stone	72
ko	72
surrogate	72
lpd	72
gene-list	72
ace	71
mv	71
salt	70
egf	69
phd	69
cox2	68
signaling	68
mgo	66
uncertainty	66
tin	65
normalization	65
mirna-target	65
association	64
acid-base	63
foxo	63
glycemia	63
enddysf	63
chinese	63
yeast	63
causation	63
jnk	62
2dge	62
simulation	62
smoking	62
me	62
pla2	61
gpcr	61
confounding	61
hts	61
ptm	61
avf	60
sas	60
melamine	60
uuo	60
change	60
outcome	60
pe	60
oral	59
eif	59
infection	59
cost	59
ifn	59
shc	59
alcohol	58
crp	58
mmp	58
robust	57
pai1	57
urate-transporter	57
nrk49f	57
llcpk1	57
fluorescence	57
achr	57
pls	57
hsp	56
semantic	56
aceiarb	56
hk2	56
calibration	56
model-selection	56
pdgf	56
competing-risk	55
oglcnac	55
goldstd	55
ratio	55
function	54
iron	54
bone	54
p-value	54
workflow	54
estrogen	54
std	53
ckd-progression	53
renoprotection	53
stem-cell	53
k	53
dipstick	53
histone	52
qc	52
ncrna	52
rho	52
ace2	52
pth	51
lod	51
fgf	51
dimerization	51
vegf	51
epidemiology	51
normoalbuminuria	51
atm	51
arsenic	50
cyclin-d1	50
mercury	50
risk-ratio	50
reasoning	50
matlab	50
antibiotics	49
epistasis	49
ab	49
hsc	49
gene-environment	49
graph	49
adpkd	49
tf	49
klotho	48
nrk52e	48
pld	48
breakpoint	48
core-curriculum	48
ukm	48
endothelium	47
joint-model	47
spot-urine	47
pooling	47
ngal	47
ffpe	47
protein-microarray	47
mesangial	47
p27	46
hdac	46
4ebp	46
aspirin	46
hgf	46
cystatin	46
fdr	46
dub	46
ecm	46
il6	46
fgf23	45
metal	45
aldosterone	45
prevention	45
semip	45
translation	45
biosensor	45
rapamycin	45
writing	45
wnt	44
variability	44
ras	44
ancova	44
bia	43
cnv	43
ccb	43
interaction	43
na	43
design	43
enos	43
sle	43
klf	43
sumo	42
agreement	42
icu	42
good	42
roc	42
bmi	42
tgfbr	41
er-stress	41
diuretics	41
stroke	41
wga	40
ampk	40
igf	40
gene-targeting	40
risk	40
alignment	40
fuzzy	40
dbdb	40
urinalysis	39
hepatocyte	39
hyperfiltration	39
dry-bw	39
qtl	39
sage	38
ap1	38
igan	38
myc	38
asia	38
protein-complex	38
hematuria	37
propensity	37
adh	37
antisense	37
animal	37
mtorc1	37
angiogenesis	37
rvh	37
haplotype	37
bh4	37
tlr	37
fabp	37
tea	37
catenin	36
megalin	36
rsk	36
omics	36
inflammasome	36
emr	36
cardiorenal	36
adenosine	36
web20	36
proteasome	35
s100b	35
chemogenomics	35
subgroup	35
candidate-gene	35
annotation	35
cre	35
gsk	35
adduct	35
pathology	34
msm	34
reverse-epidemiology	34
threshold	34
calcification	34
cross-species	34
attrition	34
sepsis	34
integrin	33
coffee	33
sp1	33
nephrotoxicity	33
zeb	33
ns	33
exercise	33
snx	33
rca	33
sarcopenia	33
fibronectin	33
cage	33
effect-size	32
text-mining	32
addgene	32
browser	32
end-point	32
il1	32
affy	32
zfn	32
orbitrap	32
gllamm	31
fc	31
hospitalization	31
frailty	31
risk-difference	31
ecology	31
blast	31
macrophage	31
vsmc	31
emsa	31
set	31
family	31
steroid	31
transactivation	31
heritability	31
knockout	30
creb	30
staging	30
abp	30
silac	30
carcinogen	30
rtk	30
notch	30
mw	30
membrane-protein	30
transporter	30
irs1	30
bmp	30
perindopril	29
pka	29
ai	29
grn	29
validation	29
reporter	29
3	29
et	29
s100	29
nutrient	29
nicotinic	29
extraction	29
virus	29
geo	28
ub-ligase	28
mutagenesis	28
time-dependent	28
race	28
scaling	28
gee	28
acetylation	28
human	27
cari	27
ce	27
classification	27
pdz	27
thesis	27
ndrd	27
ck2	27
spla2	27
mendelian	27
muscarinic	26
hplc	26
hba1c	26
agt	26
renin	26
gsh	26
thp	26
hyaluronan	26
metagenomics	26

guhjy's hcc [at least 200 articles] Export

guhjy's tags